NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
about
The glial growth factors deficiency and synaptic destabilization hypothesis of schizophreniaNeuregulin as a heart failure therapy and mediator of reverse remodelingHarnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenationNeuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclinesNeuregulin-1β induces embryonic stem cell cardiomyogenesis via ErbB3/ErbB2 receptors.RSK3: A regulator of pathological cardiac remodelingChemotherapy-Induced Cardiotoxicity: Pathophysiology and PreventionCancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Reciprocal myocardial-endocardial interactions pattern the delay in atrioventricular junction conduction.Identification of candidate genes for congenital heart defects on proximal chromosome 8p.Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab.PRAK interacts with DJ-1 and prevents oxidative stress-induced cell death.Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factorsRecombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice.Neuregulin-1β regulation of embryonic endothelial progenitor cell survival.Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failurePlatelet endothelial cell adhesion molecule-1 mediates endothelial-cardiomyocyte communication and regulates cardiac function.Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy.Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.Neuregulin-1β for the treatment of systolic heart failure.Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling.Neuregulin protects human umbilical vein endothelial cell via activating CD98hc through MAPK pathway.Cardiotoxicity of molecularly targeted agentsCardiac regenerationA specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscleMechanisms of Cardiac RegenerationRSK3 is required for concentric myocyte hypertrophy in an activated Raf1 model for Noonan syndrome.Neuregulin in cardiovascular development and diseasePalmitate alters neuregulin signaling and biology in cardiac myocytesThe role of Neuregulin-1beta/ErbB signaling in the heart.Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytesCatecholamine-induced cardiac hypertrophy in rats is associated with the activation of p70 kinase and c-Jun NH(2)-terminal kinase 2.Transcription factor ETV1 is essential for rapid conduction in the heart.Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.Signalling between microvascular endothelium and cardiomyocytes through neuregulin.Erbin is a negative modulator of cardiac hypertrophy.Cell communications in the heart.Emerging paradigms in cardiomyopathies associated with cancer therapies.
P2860
Q24798030-9C6E5F24-D204-4F14-8059-59681A9697A2Q26991903-EA7B85A2-36E7-48A0-9C64-64D26D788EACQ26995264-DC5BB00C-ECFE-4605-8FFF-BDF0AA4C2F0BQ27022965-6D3D774D-EE1F-438B-B21F-9E8DF1A1199FQ27334101-648CDDC4-BD33-42E6-A100-6287A594D82AQ28086916-5FDCA866-4EE9-4BB5-BEC3-9CD38F74135BQ30399577-E7FDC138-B15B-4B17-90AD-CE1247A5B587Q30426853-DF3CD37E-6A2F-4F0B-8FE1-DA99C6548A10Q30617471-E6322AF5-FB75-4DE7-8235-5C7873841D84Q30827321-77B5EDC8-8008-408A-89C1-18320C0BACDFQ33930241-FF685056-C1C9-48B0-A5E6-E03853A4D8C6Q34419476-BB440413-AB31-4BC9-94B6-3A68C9509910Q34507683-93702A34-98D9-4D2A-B868-D56FCE450180Q34571556-1D2906D1-07B8-4A3B-A07C-9C5FC8E00F6BQ34784347-4CBD703E-26A1-4832-A89D-DC1E6031DDD5Q34784406-B2E18A53-435D-432A-AD1C-EA0A8B55C897Q35035923-72D92F6C-C7FB-42EB-A905-7959F565246CQ35070764-46D39ED1-569E-4881-91B5-C6E071348CADQ35088053-4A04DCBA-B864-4770-9B71-27BC148CEAA1Q35164934-02D67286-D205-4893-8E87-6F8F92922912Q35207833-DD503D93-FFD3-4956-889F-982CDCA4EABAQ35231868-E97DE04E-B1FA-41CB-80F4-3DC407F4A9D6Q35836843-E303D08E-A00B-4948-A70D-BC9E15024CB3Q35870563-C530C6DF-4918-4EEF-9631-BA9D74488105Q35878459-C98483D5-CFF4-402D-8872-1DFDDFBD8D9DQ35928368-960059F9-8CA7-40C3-818E-477279C5C26CQ36204959-8F6B7050-B56D-4C6B-922E-FB3F40704C27Q36621873-39E51A97-4B82-4D83-9AE7-D257ECE0F9BEQ36839960-F675F2BB-2860-4EE7-965C-389DE00C7F0CQ37118330-1A0ED4CC-710A-4C20-A542-C761A0B07574Q37124477-73060B61-B798-4170-9A44-BD68DEE05548Q37155921-3144FBD4-7554-45DD-B060-1F4727E01369Q37189988-1B41B1C6-765B-4DB6-9A71-2BC06348BDC0Q37284655-A53E21AD-8790-4A82-91A2-83EE381C4FC2Q37452234-0FE34435-0E61-40C4-9CD3-DCA1BE9E65BFQ37474816-A4C848B8-90B9-4327-B46C-719457292221Q37707158-BD7842EF-6927-45B8-A196-2258C4C580D9Q37725186-7A36162B-FAB6-4F6B-A83A-E5F823790283Q37784108-48C06555-E347-4269-8104-9BBE2B156C53Q38132645-DE9D6268-2103-4E9C-949F-E1CA352CDA45
P2860
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
@en
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
@nl
type
label
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
@en
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
@nl
prefLabel
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
@en
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
@nl
P2093
P2860
P1476
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
@en
P2093
D B Sawyer
D R Pimental
M A Marchionni
R R Baliga
W W Simmons
P2860
P304
P356
10.1152/AJPHEART.1999.277.5.H2026
P407
P433
P577
1999-11-01T00:00:00Z